In the latest move to cement its “immunology powerhouse” status, Sanofi is handing ove | The CD20-directed antibody, dubbed ...

Among the 13 CAR-T therapeutics that have received regulatory approval are Gilead’s Yescarta and Immuneel Therapeutics’ ...

The notice comes three months after the pharmaceutical giant said it would eliminate 139 jobs at the location between February and August.

Novartis has showcased its pipeline at its annual meet-the-management day, where investors and analysts got to hear company leaders give an overview of its drug pipeline. CEO Vas Narasimhan said ...

Swiss drugmaker Roche has abandoned global diverse workforce targets and compatriot Novartis is ending its use of diverse ...

Overall, its R&D expenses amounted to $9.51 billion in 2024, continuing to grow from 2021, including due to the expansion of the pipeline of experimental drugs. From Novartis' rich portfolio of ...

Novartis said that the latest round of job losses is a result of a change in focus for its cardiovascular teams as they lower the emphasis on Entresto and devote more resources to its twice-yearly ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Basel, March 7, 2025 – Novartis shareholders today agreed to the Board of Directors’ recommendations for all proposed resolutions at the company’s Annual General Meeting (AGM). A total of 1,693 ...

Recent health news highlights include Bayer's optimism over Georgia's new law against glyphosate litigation, AstraZeneca's $1 ...

Approximately one to two people per million worldwide are diagnosed with the ultra-rare kidney disease every year ...